MicroRNA expression profiles classify human cancers
Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, et al. 2005. “MicroRNA Expression Profiles Classify Human Cancers”. Nature 435: 834-8.
Search
Search results
706 results found
MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors
Lu, J., S. Guo, B. L. Ebert, H. Zhang, X. Peng, J. Bosco, J. Pretz, et al. 2008. “MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte Progenitors”. Dev Cell 14: 843-53.
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability
Luo, T., K. Masson, J. D. Jaffe, W. Silkworth, N. T. Ross, C. A. Scherer, C. Scholl, et al. 2012. “STK33 Kinase Inhibitor BRD-8899 Has No Effect on KRAS-Dependent Cancer Cell Viability”. Proc Natl Acad Sci U S A 109: 2860-5.
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model
Majumder, P. K., J. J. Yeh, D. J. George, P. G. Febbo, J. Kum, Q. Xue, R. Bikoff, et al. 2003. “Prostate Intraepithelial Neoplasia Induced by Prostate Restricted Akt Activation: The MPAKT Model”. Proc Natl Acad Sci U S A 100: 7841-6.
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action
McFarland, J. M., B. R. Paolella, A. Warren, K. Geiger-Schuller, T. Shibue, M. Rothberg, O. Kuksenko, et al. 2020. “Multiplexed Single-Cell Transcriptional Response Profiling to Define Cancer Vulnerabilities and Therapeutic Mechanism of Action”. Nat Commun 11: 4296.
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia
Mi, S., J. Lu, M. Sun, Z. Li, H. Zhang, M. B. Neilly, Y. Wang, et al. 2007. “MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia”. Proc Natl Acad Sci U S A 104: 19971-6.
The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection
Moffett, H. F., A. N. R. Cartwright, H. J. Kim, J. Godec, J. Pyrdol, T. Aijo, G. J. Martinez, et al. 2017. “The MicroRNA MiR-31 Inhibits CD8(+) T Cell Function in Chronic Viral Infection”. Nat Immunol 18: 791-99.
Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma
Monti, S., B. Chapuy, K. Takeyama, S. J. Rodig, Y. Hao, K. T. Yeda, H. Inguilizian, et al. 2012. “Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of P53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma”. Cancer Cell 22: 359-72.
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Monti, S., K. J. Savage, J. L. Kutok, F. Feuerhake, P. Kurtin, M. Mihm, B. Wu, et al. 2005. “Molecular Profiling of Diffuse Large B-Cell Lymphoma Identifies Robust Subtypes Including One Characterized by Host Inflammatory Response”. Blood 105: 1851-61.
A functional screen identifies miRs that induce radioresistance in glioblastomas
Moskwa, P., P. O. Zinn, Y. E. Choi, S. A. Shukla, W. Fendler, C. C. Chen, J. Lu, T. R. Golub, A. Hjelmeland, and D. Chowdhury. 2014. “A Functional Screen Identifies MiRs That Induce Radioresistance in Glioblastomas”. Mol Cancer Res 12: 1767-78.